Literature DB >> 11152366

Acute methionine loading does not alter arterial stiffness in humans.

I B Wilkinson1, I L Megson, T MacCallum, D F Rooijmans, S M Johnson, J L Boyd, J R Cockcroft, D J Webb.   

Abstract

Hyperhomocystinemia is a risk factor for cardiovascular disease, and acute elevation of plasma homocysteine after methionine loading impairs endothelial function in healthy subjects. Interestingly, pretreatment with vitamin C can ameliorate this effect. We have already shown that acute oral vitamin C administration reduces arterial stiffness in healthy subjects, and the aim of the present study was to investigate the effect of methionine loading on arterial stiffness with and without concomitant vitamin C using the noninvasive technique of pulse wave analysis. Eight healthy male subjects (mean age, 29 years; range, 20-42 years) were studied on three occasions at weekly intervals. In a double-blind, double-dummy, randomized order they received orally either 100 mg/kg methionine, 100 mg/kg methionine plus 2 g of vitamin C, or matching placebos. Peripheral and central blood pressure, heart rate, cardiac index, arterial stiffness, and plasma homocysteine levels were assessed at baseline and 6 hours after dosing. Compared with placebo, there was no significant change in any of the hemodynamic parameters, including arterial stiffness, after oral methionine, although plasma homocysteine did increase from 11.5 +/- 1.6 to 28.7 +/- 4.4 microM (mean +/- SEM; p < 0.001). Combined methionine and vitamin C led to a similar increase in plasma homocysteine but significantly reduced augmentation index by 10.5 +/- 3.2% (p = 0.02). Acute hyperhomocystinemia does not significantly alter arterial stiffness, as assessed by pulse wave analysis, whereas a combination of methionine and vitamin C leads to a similar reduction in augmentation index to that previously described after vitamin C alone. These data reinforce evidence that vitamin C reduces arterial stiffness but do not indicate any important interaction with oral methionine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152366     DOI: 10.1097/00005344-200101000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Effect of methionine loading on pulse wave analysis in elderly volunteers.

Authors:  S R Hart; A A Mangoni; C G Swift; S H D Jackson
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

2.  Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline.

Authors:  François Mariotti; Alexia Hammiche; Clémence Blouet; Sophie Daré; Daniel Tomé; Jean François Huneau
Journal:  Eur J Nutr       Date:  2006-09-01       Impact factor: 5.614

Review 3.  The Role of Central Blood Pressure Monitoring in the Management of Hypertension.

Authors:  Adrian Ochoa; Gabriel Patarroyo-Aponte; Mahboob Rahman
Journal:  Curr Cardiol Rep       Date:  2018-04-19       Impact factor: 2.931

4.  Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function.

Authors:  K R Davis; H Pearson; S Moat; J R Bonham; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 5.  Metabolomics of Arterial Stiffness.

Authors:  Kaido Paapstel; Jaak Kals
Journal:  Metabolites       Date:  2022-04-20

Review 6.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

7.  N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.

Authors:  A T Treweeke; T J Winterburn; I Mackenzie; F Barrett; C Barr; G F Rushworth; I Dransfield; S M MacRury; I L Megson
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

8.  Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.

Authors:  Kyle R Gibson; Tim J Winterburn; Fiona Barrett; Sushma Sharma; Sandra M MacRury; Ian L Megson
Journal:  Cardiovasc Diabetol       Date:  2011-05-21       Impact factor: 9.951

Review 9.  The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect?

Authors:  Ovidiu Mitu; Ioana Alexandra Cirneala; Andrada Ioana Lupsan; Mircea Iurciuc; Ivona Mitu; Daniela Cristina Dimitriu; Alexandru Dan Costache; Antoniu Octavian Petris; Irina Iuliana Costache
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.